immunosuppressive
[대역어] 면역억제제
[용어속성] Term
[용어속성] Term
Voclosporin: First Approval
보클로스포린: 최초 승인
Review
[키워드] approval
calcineurin
Combination
coronavirus disease
Coronavirus disease 2019
COVID-19
immunosuppressive
immunosuppressive therapy
inhibitor
kidney transplant recipients
LUPKYNIS
lupus nephritis
Novel coronavirus
novel coronavirus disease
positive result
regimen
therapy
trials
USA
voclosporin
[DOI] 10.1007/s40265-021-01488-z PMC 바로가기 [Article Type] Review
[DOI] 10.1007/s40265-021-01488-z PMC 바로가기 [Article Type] Review
Management of liver disease patients in different clinical situations during COVID-19 pandemic
Review
[키워드] acute respiratory syndrome
Admission
Adults
Autoimmune
available data
basic
children
China
chronic
chronic liver disease
Chronic Liver Diseases
clearance
coronavirus
Course
COVID-19
COVID-19 infection
COVID-19 pandemic
decrease
deficiency
disease
drug
Evidence
Fatty liver
Follow-up
HBV
healthcare
healthcare worker
hemochromatosis
hepatitis B
hepatitis C
Hepatocellular carcinoma
Immunosuppression
immunosuppressive
increased risk
infected with COVID-19
Infection
infection with COVID-19
liver
Liver cirrhosis
Liver disease
liver diseases
liver enzyme
management
Mild
obese patient
Patient
patients
Personal protective equipment
poor prognosis
preliminary report
recipient
reported
SARS-CoV-2
severity
severity of COVID-19
Spread
Telemedicine
therapy
Viral hepatitis
Wilson’s disease
[DOI] 10.1186/s43066-021-00091-x PMC 바로가기 [Article Type] Review
[DOI] 10.1186/s43066-021-00091-x PMC 바로가기 [Article Type] Review
Aging and Interferons: Impacts on Inflammation and Viral Disease Outcomes
Review
[키워드] Adaptive immune response
aging
antiviral response
cause
COVID-19
Critical
death
dendritic cell
disease pathology
dysregulation
Elderly patient
Evidence
exacerbated
function
global pandemic
IFN
IFN response
IFNs
immune activation
immune response
Immune-mediated
immunopathology
immunosuppressive
Impact
impairment
implication
individual
individuals
Infection
Inflammation
Inflammatory
inflammatory immune responses
interferon
involved
Macrophage
magnitude
majority
monocyte/macrophages
outcome
pathology
Prevent
promote
Regulation
response
Severe infection
Support
tissue pathology
treat
type I
Type I IFN
type II IFN
Type III IFN
understanding
viral infection
viral replication
[DOI] 10.3390/cells10030708 PMC 바로가기 [Article Type] Review
[DOI] 10.3390/cells10030708 PMC 바로가기 [Article Type] Review
Judicious use of low-dosage corticosteroids for non-severe COVID-19: A case report
Case Report
[키워드] acute respiratory distress
acute respiratory distress syndrome
Administered
administration of corticosteroid
antiviral drugs
ARDS
attenuate
Case report
chest CT scan
China
complete recovery
Coronavirus disease 2019
Corticosteroid
corticosteroid therapy
COVID-19
COVID-19 case
COVID-19 disease
critical COVID-19 patient
Cytokine storm
death
Disease progression
dosage
Efficacy
Evidence
facilitated
immunosuppressive
infection with SARS-CoV-2
Inflammatory
lack
lung
Lung inflammation
Lung injury
Methylprednisolone
Personalized medicine
progression
reduction in
Regular
Respiratory failure
retrospective
Safe
SARS-CoV-2
Severe case
supportive care
syndrome
systemic corticosteroid
Therapeutic approach
therapy
Treatment
use of corticosteroid
was recorded
WHO
[DOI] 10.1515/med-2021-0250 PMC 바로가기 [Article Type] Case Report
[DOI] 10.1515/med-2021-0250 PMC 바로가기 [Article Type] Case Report
Interleukin-6 blocking agents for treating COVID-19: a living systematic review
COVID-19 치료를 위한 인터루킨-6 차단제: 살아있는 체계적인 검토
Meta-Analysis
[키워드] 95% CI
adverse event
adverse events
age
all-cause mortality
anti-IL6
approach
articles
available data
average
baseline
benefit
Bia
blocking agent
blocking agents
Brazil
can not
Care
certainty
certainty of evidence
China
clinical
Clinical improvement
Cochrane COVID-19 Study Register
collected data
conducted
coronavirus disease
Coronavirus disease 2019
COVID-19
Critical
Critical disease
Data collection
death
defined
disease
disease severity
Efficacy and safety
eight
evaluate
evaluated
Evidence
excluded
FIVE
Follow-up
France
Health Organization
heterogeneity
hospital discharge
identify
IL-6
IL-6 blocking
Immune system dysfunction
immunosuppressive
incidence
Inclusion
individual
individual patient data meta-analyses
Inflammation
interleukin
interleukin 6
interleukin 6 (IL-6
Intubated
intubated patient
intubated patients
Italy
male
mechanical ventilation
Meta-analysis
methodology
Mild
moderate
Mortality
multicentre
nine
no increase
not intubated
organ support
Other outcomes
outcome
outcomes
oxygen
participant
Participants
Patient
patient data
patients with COVID-19
peer-reviewed
people with COVID-19
Placebo
platform
Platform trial
progression
proportion
protocol
randomised
randomised controlled trial
Randomised controlled trials
ranged
RCT
RCTs
reduce
Registered
registry
reported
risk of bia
Safety
sarilumab
score
searched
Selection
Serious Adverse Event
Serious Adverse Events
Seven
severe coronavirus disease
severity
siltuximab
standard care
Standard of care
subgroups of patient
systematic review
Tocilizumab
Tolerance
Treatment
Trial
trial participant
trial participants
trials
unlikely
USA
WHO
World Health Organization
[DOI] 10.1002/14651858.CD013881 PMC 바로가기 [Article Type] Meta-Analysis
[DOI] 10.1002/14651858.CD013881 PMC 바로가기 [Article Type] Meta-Analysis
Successful pulsed methylprednisolone and convalescent plasma treatment in a case of a renal transplant recipient with COVID-19 positive pneumonia: a case report
Case Report
[키워드] Affect
cadaver
Case report
caused
convalescent plasma
Convalescent plasma therapy
convalescent plasma treatment
cough
COVID-19
COVID-19 infection
COVID-19 patient
COVID-19 patients
death
disease
Fever
FIVE
Follow-up
immunosuppressive
male
Methylprednisolone
Moderate COVID-19
mortality rate
Patient
performed
plasma
Pneumonia
positive
presenting
protocol
pulse steroid therapy
radiological improvement
recipient
recipients
renal
Renal transplantation
Respiratory system
Severe COVID-19 pneumonia
Shortness of breath
specific treatment
therapy
Thorax
tomography
Treatment
with COVID-19
Wuhan, China
[DOI] 10.11604/pamj.2021.38.273.28577 PMC 바로가기 [Article Type] Case Report
[DOI] 10.11604/pamj.2021.38.273.28577 PMC 바로가기 [Article Type] Case Report
Elevated frequencies of CD14 + HLA-DR lo/neg MDSCs in COVID-19 patients
COVID-19 환자에서 CD14 + HLA-DR lo/neg MDSC의 빈도 증가
Research Paper
[키워드] albumin
analyzed
association
B cell
CD14
Cell
change
Clinical characteristics
correlated
correlation
COVID-19
COVID-19 patient
COVID-19 patients
COVID-19 progression
COVID-19 severity
determined by
disease severity
elevated
evaluate
flow cytometry
Follow-up
Frequency
greater
HLA-DR
Hospital stay
hyper-inflammation
ICU patient
immune responses
immunoparalysis
Immunosuppression
immunosuppressive
laboratory data
lymphocyte
Lymphocyte count
lymphocyte counts
MDSC
Most patients
NK cell
nucleic acid
Oropharyngeal
Patient
percentage
percentages
positively correlated
Prognosis
SARS-CoV-2
SARS-CoV-2 nucleic acid
serum albumin
severe patients
T cell
Viral
Viral load
[DOI] 10.18632/aging.202571 PMC 바로가기 [Article Type] Research Paper
[DOI] 10.18632/aging.202571 PMC 바로가기 [Article Type] Research Paper
COVID-19 in Children With Liver Disease
Pediatrics
[키워드] Adults
association
asymptomatic infection
Autoimmune
Care
caused
children
chronic conditions
chronic liver disease
CLD
Clinical course
Complication
component
concerning
COVID-19
COVID-19 infection
COVID-19 patients
database
disease
evaluate
General population
global pandemic
Health
healthy
highlight
hypoxia
Immunosuppressed
immunosuppressive
Immunosuppressive medication
Immunosuppressive treatment
increased risk
infected with COVID-19
literature review
liver cells
Liver disease
liver dysfunction
Liver injury
Liver transplantation
maintain
majority
medication
Mild
multicenter
National
outbreak
Patient
preserved
Prevent
rejection
remained
reported
required
Research
resulting
SARS-CoV-2
SARS-CoV-2 disease
SARS-COV-2 infection
severe disease course
transaminases
viral infection
was performed
with COVID-19
[DOI] 10.3389/fped.2021.616381 PMC 바로가기 [Article Type] Pediatrics
[DOI] 10.3389/fped.2021.616381 PMC 바로가기 [Article Type] Pediatrics
Humoral response to COVID-19 infection in immunosuppressed patients with inflammatory bowel disease
염증성 장질환이 있는 면역억제 환자의 코로나19 감염에 대한 체액 반응
Case Reports
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
Admission
advanced age
Anosmia
antibody
Antibody testing
cardiovascular diseases
clinical manifestation
Comorbidity
coronavirus
Course
COVID-19
COVID-19 infection
described
determined by
diabetes
diarrhea
disease severity
dysgeusia
hospital
Humoral response
hypertension
IBD
ICU
immune response
immunosuppressed patient
Immunosuppression
immunosuppressive
Immunosuppressive medication
immunosuppressive therapy
Immunosuppressive treatment
Indicator
Infection
Inflammatory bowel disease
initial symptoms
management
older patient
older patients
Patient
patients
patients with COVID-19
PCR
Pyrexia
respiratory
restart
SARS-CoV-2
SARS-CoV-2 antibody
SARS-CoV-2 antibody testing
severe acute respiratory syndrome Coronavirus
symptoms of COVID-19
tested
therapy
virus-specific antibodies
[DOI] 10.1097/MEG.0000000000002094 PMC 바로가기 [Article Type] Case Reports
[DOI] 10.1097/MEG.0000000000002094 PMC 바로가기 [Article Type] Case Reports